CELforPharma
Board
1 director, last change in 2022- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 18-02-2022
Mandates through the years
4 names, the dashed line is todayLAICO4Growth BV
Director
Director
LAICO4Growth
Director (not named in the articles)
Director (not named in the articles)
LAICO4Growth
Director (not named in the articles)
Director (not named in the articles)
Luc De Langhe
Sole director (not named in the articles)
Sole director (not named in the articles)
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
- LAICO4Growth BV
- Director, since before 31-12-2025
- LAICO4Growth
- Director (not named in the articles), from before 31-12-2021, no longer listed in the 2025 annual accounts
- LAICO4Growth
- Director (not named in the articles), appointed by deed of 18-02-2022, no longer listed in the 2025 annual accounts
- Luc De Langhe
- Sole director (not named in the articles), from before 31-12-2021 to 18-02-2022
Control
Parent
Equity €919,578
Profit €128,731 in 2026 (profit €121,328 in 2025)
Source: accounts LAICO4Growth 31-03-2026
100%
This company
CELforPharma
Equity €323,248
Loss €21,251 in 2025
Capital
- Contribution
- €20,000
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- LAICO4Growth
Source: lists of holdings in the owners' accounts
Articles of association
deed of 18-02-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Friday of May at 16:00